Literature DB >> 22030458

Expression of profibrotic genes in a murine remnant kidney model.

Binxia Yang1, Pawan K Vohra, Rajiv Janardhanan, Khamal D Misra, Sanjay Misra.   

Abstract

PURPOSE: To test the hypothesis that there is increased expression of several profibrotic genes, including matrix metalloproteinase (MMP)-2 and MMP-9 and tissue inhibitors of metalloproteinase (TIMP-1 and TIMP-2), a disintegrin and metalloproteinase with thrombospondin motif-1 (ADAMTS-1), and fibroblast specific protein-1 (FSP-1) in a murine remnant kidney model.
MATERIALS AND METHODS: Chronic kidney disease (CKD) was created in 10 C57BL/6 male mice (20-25 g) by performing a right nephrectomy and ligation of the upper pole of the left kidney (remnant kidney). Animals were sacrificed 42 days and 56 days later. Reverse transcriptase polymerase chain reaction (RT-PCR) for MMP-2, MMP-9, TIMP-1, TIMP-2, ADAMTS-1, and FSP-1 was performed in the remnant kidney. Histologic evaluation of the remnant kidney was performed using Ki-67, α-smooth muscle cell actin (α-SMA), hematoxylin and eosin, and Masson' trichrome staining. Kidney function was assessed using serum blood urea nitrogen (BUN) and creatinine.
RESULTS: The mean serum BUN and creatinine levels at day 42 and day 56 were significantly higher than baseline (P < .05). By day 42, the mean expression of MMP-2, MMP-9, TIMP-1, ADAMTS-1, and FSP-1 was significantly higher in the remnant kidney compared with the normal kidney (P < .05); by day 56, only FSP-1 expression was significantly higher (P < .05). There was increased fibrosis by Masson' trichrome, increased Ki-67, and increased α-SMA staining in the remnant kidney compared with the normal kidney.
CONCLUSIONS: In the remnant kidney, there was increased fibrosis with increased α-SMA and Ki-67 staining and significantly increased expression of MMP-2, MMP-9, TIMP-1, ADAMTS-1, and FSP-1.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22030458      PMCID: PMC3224153          DOI: 10.1016/j.jvir.2011.08.026

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  37 in total

1.  Secular trends in cardiovascular disease risk factors according to body mass index in US adults.

Authors:  Edward W Gregg; Yiling J Cheng; Betsy L Cadwell; Giuseppina Imperatore; Desmond E Williams; Katherine M Flegal; K M Venkat Narayan; David F Williamson
Journal:  JAMA       Date:  2005-04-20       Impact factor: 56.272

2.  Adventitial remodeling with increased matrix metalloproteinase-2 activity in a porcine arteriovenous polytetrafluoroethylene grafts.

Authors:  Sanjay Misra; Michael G Doherty; David Woodrum; Jay Homburger; Jaywant N Mandrekar; Stephane Elkouri; Enrique A Sabater; Haraldur Bjarnason; Alex A Fu; James F Glockner; Eddie L Greene; Debabrata Mukhopadhyay
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

3.  Localization of matrix metalloproteinases and their inhibitors in experimental progressive kidney scarring.

Authors:  A K Ahmed; J L Haylor; A M El Nahas; T S Johnson
Journal:  Kidney Int       Date:  2007-02-07       Impact factor: 10.612

4.  Prevalence of chronic kidney disease in the United States.

Authors:  Josef Coresh; Elizabeth Selvin; Lesley A Stevens; Jane Manzi; John W Kusek; Paul Eggers; Frederick Van Lente; Andrew S Levey
Journal:  JAMA       Date:  2007-11-07       Impact factor: 56.272

5.  Renal ischemia reperfusion inhibits VEGF expression and induces ADAMTS-1, a novel VEGF inhibitor.

Authors:  David P Basile; Katherine Fredrich; Bhadrani Chelladurai; Ellen C Leonard; Alan R Parrish
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-13

6.  cDNA microarray analysis of adaptive changes after renal ablation in a sclerosis-resistant mouse strain.

Authors:  Brigitta Rumberger; Oliver Vonend; Clemens Kreutz; Jochen Wilpert; Johannes Donauer; Kerstin Amann; Rolf Rohrbach; Jens Timmer; Gerd Walz; Peter Gerke
Journal:  Kidney Blood Press Res       Date:  2007-09-20       Impact factor: 2.687

Review 7.  Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin.

Authors:  Pierre Ronco; Brigitte Lelongt; Rémi Piedagnel; Christos Chatziantoniou
Journal:  Semin Nephrol       Date:  2007-05       Impact factor: 5.299

8.  Expression and significance of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS)-1 in an animal model of renal interstitial fibrosis induced by unilateral ureteral obstruction.

Authors:  Atsushi Nakamura; Yukiko Sakai; Chieri Ohata; Toshi Komurasaki
Journal:  Exp Toxicol Pathol       Date:  2007-06-20

9.  Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors.

Authors:  Sunyoung Lee; Shahla M Jilani; Ganka V Nikolova; Darren Carpizo; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

10.  Mechanisms of progression of chronic kidney disease.

Authors:  Agnes B Fogo
Journal:  Pediatr Nephrol       Date:  2007-07-24       Impact factor: 3.714

View more
  6 in total

Review 1.  New Insights into Dialysis Vascular Access: Molecular Targets in Arteriovenous Fistula and Arteriovenous Graft Failure and Their Potential to Improve Vascular Access Outcomes.

Authors:  Timmy Lee; Sanjay Misra
Journal:  Clin J Am Soc Nephrol       Date:  2016-07-11       Impact factor: 8.237

Review 2.  The Biology of Hemodialysis Vascular Access Failure.

Authors:  Akshaar Brahmbhatt; Sanjay Misra
Journal:  Semin Intervent Radiol       Date:  2016-03       Impact factor: 1.513

3.  Therapeutic Effect of Adipose Derived Mesenchymal Stem Cell Transplantation in Reducing Restenosis in a Murine Angioplasty Model.

Authors:  Chuanqi Cai; Sreenivasulu Kilari; Chenglei Zhao; Michael L Simeon; Avanish Misra; Yiqing Li; Andre J van Wijnen; Debabrata Mukhopadhyay; Sanjay Misra
Journal:  J Am Soc Nephrol       Date:  2020-06-25       Impact factor: 10.121

4.  Anti Human CX3CR1 VHH Molecule Attenuates Venous Neointimal Hyperplasia of Arteriovenous Fistula in Mouse Model.

Authors:  Sanjay Misra; Sreenivasulu Kilari; Binxia Yang; Amit Sharma; Chih-Cheng Wu; Roberto I Vazquez-Padron; John Broadwater
Journal:  J Am Soc Nephrol       Date:  2021-04-23       Impact factor: 14.978

5.  MMP-9 Deletion Attenuates Arteriovenous Fistula Neointima through Reduced Perioperative Vascular Inflammation.

Authors:  Yu-Chung Shih; Po-Yuan Chen; Tai-Ming Ko; Po-Hsun Huang; Hsu Ma; Der-Cherng Tarng
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

Review 6.  The molecular mechanisms of hemodialysis vascular access failure.

Authors:  Akshaar Brahmbhatt; Andrea Remuzzi; Marco Franzoni; Sanjay Misra
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.